Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP2 | P42575 | 1/20 | 0.62 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.61 |
| ▸ | NAAA | Q02083 | 1/20 | 0.58 |
| ▸ | EPHX1 | P07099 | 7/20 | 0.57 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.48 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31620140 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL5353889 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL1826713 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL18871729 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL31620138 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL18402599 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL13123173 | 1.00 | CASP2 (0.62) | CASP2DNM1NAAAEPHX1FAAH | |
| Hydrochloric Acid SCHEMBL11416125 | 0.98 | CASP2 (0.60) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL13970681 | 0.92 | DNM1 (0.55) | CASP2DNM1NAAAEPHX1FAAH | |
| SCHEMBL1828419 | 0.92 | MEN1 (0.52) | CASP2DNM1NAAAEPHX1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240226132-A1 | RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME | BIONTECH DELIVERY TECHNOLOGIES GMBH (DE) | 2024-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240226132-A1 | RNA COMPOSITIONS COMPRISING A BUFFER SUBSTANCE AND METHODS FOR PREPARING, STORING AND USING THE SAME | SNRPB2, NSUN2, RNMT | CASP2 3765/4885DNM1 2067/4885NAAA 3293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.